Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?
暂无分享,去创建一个
[1] A. M. Skene,et al. TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.
[2] T. Meinertz,et al. The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction. , 1988, The American journal of cardiology.
[3] L. Bolognese,et al. RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 , 1988, The Lancet.
[4] E. Braunwald,et al. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial. , 1988, The American journal of cardiology.
[5] F. Sheehan,et al. Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinant of survival. , 1988, Journal of the American College of Cardiology.
[6] P. Sager,et al. Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation. , 1988, Journal of the American College of Cardiology.
[7] M. Weisfeldt,et al. Cellular mechanisms of myocardial infarct expansion. , 1988, Circulation.
[8] E. B. Carlson,et al. Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction. , 1988, Journal of the American College of Cardiology.
[9] M. O'Rourke,et al. Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator. , 1988, Circulation.
[10] Aims Trial Study Group. EFFECT OF INTRAVENOUS APSAC ON MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION: PRELIMINARY REPORT OF A PLACEBO-CONTROLLED CLINICAL TRIAL , 1988, The Lancet.
[11] F. Sheehan,et al. Improved survival up to four years after early coronary thrombolysis. , 1988, The American journal of cardiology.
[12] T. Force,et al. Acute reduction in functional infarct expansion with late coronary reperfusion: assessment with quantitative two-dimensional echocardiography. , 1988, Journal of the American College of Cardiology.
[13] W. Grossman,et al. Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis. , 1988, Journal of the American College of Cardiology.
[14] E. Topol,et al. A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. , 1987, The New England journal of medicine.
[15] B. Chaitman,et al. The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty. , 1987, Journal of the American College of Cardiology.
[16] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.. LONG-TERM EFFECTS OF INTRAVENOUS THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: FINAL REPORT OF THE GISSI STUDY , 1987, The Lancet.
[17] H. White,et al. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. , 1987, The New England journal of medicine.
[18] E. Braunwald. The path to myocardial salvage by thrombolytic therapy. , 1987, Circulation.
[19] T Sandor,et al. Differential effects of reperfusion on incidence of ventricular arrhythmias and recovery of ventricular function at 4 days following coronary occlusion. , 1987, American heart journal.
[20] R. Jeremy,et al. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. , 1987, Journal of the American College of Cardiology.
[21] F H Sheehan,et al. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. , 1987, Circulation.
[22] J. Hochman,et al. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. , 1987, Circulation.
[23] E. E. van der Wall,et al. Prediction of spontaneous coronary reperfusion in myocardial infarction. , 1986, Postgraduate medical journal.
[24] W Grossman,et al. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. , 1986, Circulation.
[25] J. Ritchie,et al. Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. The Western Washington Intracoronary Streptokinase Trial. , 1986, Circulation.
[26] W. Stevenson,et al. Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study. , 1986, Journal of the American College of Cardiology.
[27] M. Simoons,et al. REDUCED FREQUENCY OF VENTRICULAR FIBRILLATION AFTER EARLY THROMBOLYSIS IN MYOCARDIAL INFARCTION , 1986, The Lancet.
[28] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[29] M. Pfeffer,et al. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. , 1985, Circulation.
[30] M. Pfeffer,et al. Influence of Chronic Captopril Therapy on the Infarcted Left Ventricle of the Rat , 1985, Circulation research.
[31] J L Ritchie,et al. The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report. , 1985, The New England journal of medicine.
[32] J. Ritchie,et al. Global and regional left ventricular function and tomographic radionuclide perfusion: the Western Washington Intracoronary Streptokinase In Myocardial Infarction Trial. , 1984, Circulation.
[33] J L Ritchie,et al. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. , 1983, The New England journal of medicine.
[34] E. E. van der Wall,et al. Effects of Spontaneous and Streptokinase‐induced Recanalization on Left Ventricular Function After Myocardial Infarction , 1983, Circulation.
[35] E. Braunwald,et al. Topographic changes in the left ventricle after experimentally induced myocardial infarction in the rat. , 1983, The American journal of cardiology.
[36] J S Hochman,et al. Expansion of acute myocardial infarction: an experimental study. , 1982, Circulation.
[37] J. Weiss,et al. Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. , 1982, The American journal of cardiology.
[38] L. W. Eaton,et al. Expansion of Acute Myocardial Infarction: Its Relationship to Infarct Morphology in a Canine Model , 1981, Circulation research.
[39] W. Kannel,et al. Prognosis after initial myocardial infarction: the Framingham study. , 1979, The American journal of cardiology.
[40] G. Hutchins,et al. Infarct expansion versus extension: two different complications of acute myocardial infarction. , 1978, The American journal of cardiology.